Skip to main content
Equibles
IDYA logo

IDYA · IDEAYA Biosciences, Inc.

Track IDYA — free

Use IDYA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about IDYA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$36.30 -0.38 (-1.04%) At close · Aug 14
Market Cap
$3.50B
Shares
96.49M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
10,491,921 +3.7% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
84/100
Short interest 10.5% of shares — P91 Days to cover 13.2 — P93 Price vs VWAP +8.2% — P76 Short-volume trend +9.1% — P81 Short interest change +5.6% — P72 Worst FTD 0.10% of shares — P77

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 10,113,206 9,573,580 +539,626 13.19
    2026-07-15 9,573,580 10,334,969 -761,389 8.61
    2026-06-30 10,334,969 10,629,114 -294,145 6.08
    2026-06-15 10,629,114 11,338,312 -709,198 7.53
    2026-05-29 11,338,312 11,704,298 -365,986 16.34
    2026-05-15 11,704,298 11,705,770 -1,472 13.96
    2026-04-30 11,705,770 10,564,351 +1,141,419 11.18
    2026-04-15 10,564,351 9,761,427 +802,924 4.53
    2026-03-31 9,761,427 9,723,966 +37,461 9.35
    2026-03-13 9,723,966 9,732,265 -8,299 11.38
    2026-02-27 9,732,265 9,995,587 -263,322 12.67
    2026-02-13 9,995,587 9,316,949 +678,638 11.52
    2026-01-30 9,316,949 8,705,576 +611,373 11.59
    2026-01-15 8,705,576 8,247,135 +458,441 8.38
    2025-12-31 8,247,135 7,223,004 +1,024,131 9.47
    2025-12-15 7,223,004 7,717,025 -494,021 7.49
    2025-11-28 7,717,025 8,033,340 -316,315 9.14
    2025-11-14 8,033,340 7,859,556 +173,784 8.52
    2025-10-31 7,859,556 8,481,677 -622,121 5.71
    2025-10-15 8,481,677 8,393,673 +88,004 7.37
    2025-09-30 8,393,673 9,459,498 -1,065,825 6.52
    2025-09-15 9,459,498 10,088,795 -629,297 5.66
    2025-08-29 10,088,795 9,648,848 +439,947 13.16
    Showing 1–23 of 23 settlements
    Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 271 filings 265 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)